Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
BMC Cancer
|
November 18, 2021
The landscape of coding RNA editing events in pediatric cancer
Ji Wen, Michael Rusch, Samuel W Brady, et al.
BMC Bioinformatics
|
June 28, 2023
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Alyssa N Obermayer, Darwin Chang, Gabrielle Nobles, et al.
Research Square
|
January 23, 2024
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Timothy I Shaw, Jessica Wagner, Liqing Tian, et al.
Nature Communications
|
May 3, 2024
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Timothy I Shaw, Jessica Wagner, Liqing Tian, et al.
Neuro-Oncology
|
December 15, 2020
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery
Dalia Haydar, Haley Houke, Jason Chiang, et al.
Journal for Immunotherapy of Cancer
|
November 21, 2024
IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors
Elizabeth Wickman, Shannon Lange, Jessica Wagner, et al.
Cancer Cell
|
November 22, 2024
Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity
Kay Hänggi, Jie Li, Achintyan Gangadharan, et al.
Molecular Cell
|
May 21, 2016
The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis
Joung Hyuck Joo, Bo Wang, Elisa Frankel, et al.
Molecular Cell
|
June 18, 2016
The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis
Joung Hyuck Joo, Bo Wang, Elisa Frankel, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2025
Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients
Mate Z Nagy, Lourdes B Plaza-Rojas, Justin C Boucher, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
BMC Cancer
|
November 18, 2021
The landscape of coding RNA editing events in pediatric cancer
Ji Wen, Michael Rusch, Samuel W Brady, et al.
BMC Bioinformatics
|
June 28, 2023
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Alyssa N Obermayer, Darwin Chang, Gabrielle Nobles, et al.
Research Square
|
January 23, 2024
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Timothy I Shaw, Jessica Wagner, Liqing Tian, et al.
Nature Communications
|
May 3, 2024
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Timothy I Shaw, Jessica Wagner, Liqing Tian, et al.
Neuro-Oncology
|
December 15, 2020
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery
Dalia Haydar, Haley Houke, Jason Chiang, et al.
Journal for Immunotherapy of Cancer
|
November 21, 2024
IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors
Elizabeth Wickman, Shannon Lange, Jessica Wagner, et al.
Cancer Cell
|
November 22, 2024
Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity
Kay Hänggi, Jie Li, Achintyan Gangadharan, et al.
Molecular Cell
|
May 21, 2016
The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis
Joung Hyuck Joo, Bo Wang, Elisa Frankel, et al.
Molecular Cell
|
June 18, 2016
The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis
Joung Hyuck Joo, Bo Wang, Elisa Frankel, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2025
Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients
Mate Z Nagy, Lourdes B Plaza-Rojas, Justin C Boucher, et al.
Page
of 8